MetaStat, Inc.
company.status.inactiveCIK 1404943fmd_1ZPS4VY5A004GJWNSJ6DME4F6DManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Mar 01, 2008 to Feb 28, 2018, 33 periods
| Line item | FY2009 | FY2010 | FY2011 | FY2012 | FY2013 | FY2014 | FY2015 | FY2016 | FY2017 | FY2018 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | – | 0 | 0 | 0 | 0 |
| Net interest income | – | – | – | – | (0) | 0 | 0 | – | – | – |
| Research and development | – | – | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Total operating expenses | – | – | 0 | 2 | 3 | 4 | 5 | 5 | 3 | 4 |
| Interest expense | – | – | – | – | 0 | 0 | 1 | 0 | 1 | 0 |
| Net income | (0) | (0) | (0) | (2) | (3) | (5) | (8) | (5) | (3) | (3) |
| Net income to common shareholders | – | – | – | – | – | (5) | (8) | (6) | (6) | (3) |